how does glp 1 medication work GLP-1 Medications Actually in Your Body GLP-1 Agonists - What is

doi: 10.1111/j.1753-4887.2011.00444.x

Building on the therapeutic success of GLP-1RAs, recent pharmacological developments have introduced GLP-1 with glucose-dependent insulinotropic polypeptide (GIP)/glucagon (GCG) dual or triple receptor agonists simultaneously target multiple incretin pathways, offering a novel multi-targeted approach to MASLD treatment

Although the carboxyl-molecules can be made to react directly with amines using EDC, the reaction is much more efficient with NHS because a stable intermediate is created

Typical Timeline: First few days: Appetite suppression begins as the medication takes effect Weeks 1-4: Reduced caloric intake leads to initial weight loss Weeks 5-12: Steady weight loss continues, with most patients seeing 5% body weight loss by week 12 3-6 months: Many patients achieve 10% or more total body weight loss Plateau Management: Some patients experience plateaus, which is normal